Jhi‐Joung Wang
Papers
1
Total Citations
6
H-Index
1
About
Jhi-Joung Wang is a clinical researcher whose work centers on surgical outcomes, quality-of-life (QOL) assessment, and advanced biostatistical methods in oncology, particularly for hepatocellular carcinoma (HCC). Wang’s most cited study, a 2022 prospective longitudinal cohort analysis, applied inverse probability of treatment weighting to compare five-year QOL trajectories across three surgical procedures for HCC. This work not only tracked long-term changes in individual QOL subscales but also identified key predictors of effective recovery, offering actionable insights for patient-centered surgical decision-making. With over 500 HCC patients enrolled, the study underscores Wang’s commitment to rigorous, real-world evidence. By integrating sophisticated causal inference techniques into surgical research, Wang has advanced the field’s ability to disentangle treatment effects from confounding variables, directly impacting how clinicians evaluate and counsel patients. This contribution, alongside a broader portfolio of outcomes research, has earned Wang recognition for bridging methodological innovation with clinical relevance—a hallmark of their career.
Research Focus
Key Achievements
Top Papers
- 1